Clinical Trial Update: Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1b/2 trial evaluating the triplet of carfilzomib, carboplatin, and etoposide in previously untreated extensive-stage small-cell lung cancer has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Carfilzomib (carfilzomib)
• Etoposide (Etoposide)

Snippet

Sponsor: Amgen | Conditions: Extensive-Stage Small-Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-08-28